Clinical Trials Directory

Trials / Terminated

TerminatedNCT00512369

Effects of PA-1 Transcriptional Regulation on Monocyte Function

Angiotensin, the Vascular Endothelium, and Fibrinolysis - The Effects of PAI-1 Transcriptional Regulation on Human Monocyte Function

Status
Terminated
Phase
Study type
Observational
Enrollment
125 (estimated)
Sponsor
Vanderbilt University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Researching genetic differences in people with no prior medical conditions for better understanding of cardiac diseases through genetic research.

Detailed description

The discovery and subsequent application of small interfering RNA (siRNA) methods to achieve individual gene silencing in mammalian cells is a robust method that is well-described and validated in mammalian cell culture systems. We will apply this technique to achieve post-transcriptional "silencing" of PAI-1 in monocytes obtained from otherwise healthy volunteers, and study the subsequent loss of this gene's function on the migratory capacity of these cells in the proposed in vitro experimental system. This concept has not yet been demonstrated in the literature, and if validated, would be a novel and fundamental description of the role of PAI-1 in human monocyte biology as related to the development of atherosclerosis.

Conditions

Timeline

Start date
2006-03-01
Completion
2011-07-01
First posted
2007-08-07
Last updated
2011-07-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00512369. Inclusion in this directory is not an endorsement.